RESUMO
The aim of this study was to estimate the concentration of total selenium in serum women with thyroid gland disease. Selenium was determined by atomic absorption spectrometry using the hydride generation method (HG-AAS). Research was determined in 94 patients with thyroid gland disease and in 28 healthy controls. Selenium concentration of serum was variously in patients than in control group and patients with different thyroid gland diseases. Concentration in control group was 0.06231 microg/ml, in goitre group--0.05612 microg/ml, in hyperthyroidism--0.07149 microg/ml and in hypothyroidism--0.09088 microg/ml.
Assuntos
Selênio/sangue , Doenças da Glândula Tireoide/sangue , Doenças da Glândula Tireoide/classificação , Saúde da Mulher , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Humanos , Hipertireoidismo/sangue , Hipertireoidismo/classificação , Hipotireoidismo/sangue , Hipotireoidismo/classificação , Pessoa de Meia-Idade , Polônia , Valores de Referência , Espectrofotometria Atômica/métodosRESUMO
The aim of this study was to estimate the concentration of total selenium in serum women with thyroid gland disease. Selenium was determined by atomic absorption spectrometry using the hydride generation technique (HG-AAS). Selenium was determined in 30 patients with thyroid gland disease and in 12 healthy controls. Selenium concentration of serum was variously in patients than in control group and patients with different thyroid gland disease. The average concentration of selenium in control group was 0.0694 microg/ml, in goiter group 0.0529 microg/ml, in hyperactivity group 0.0441 microg/ml, in hypofunction group 0.0520 microg/ml.g/ml.
